Unknown OBSERVATIONAL NCT01258127

Pemetrexed/Carboplatin vs Vinorelbine/Carboplatin in Patients With Completely Resected Non-small Cell Lung Cancer (NSCLC)

Adjuvant Chemotherapy of Pemetrexed/Carboplatin Compared With Vinorelbine/Carboplatin in Patients With Completely Resected NSCLC

Sponsor: Shanghai Nancy Medical Sci-Tech Co. Ltd

Conditions Non-small Cell Lung Cancer

Updated 5 times since 2017 Last updated: Dec 9, 2010 Started: Aug 31, 2010 Primary completion: Aug 31, 2012 Completion: Aug 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01258127, this observational or N/A phase trial focuses on Non-small Cell Lung Cancer and remains ongoing. Sponsored by Shanghai Nancy Medical Sci-Tech Co. Ltd, it has been updated 5 times since 2010, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Apr 2018 — Jan 2021 [monthly]

Unknown Status

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Unknown Status NA

First recorded

Aug 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shanghai Nancy Medical Sci-Tech Co. Ltd
Sichuan Cancer Hospital and Research Institute

Data source: Shanghai Nancy Medical Sci-Tech Co. Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chengdu, China